» Articles » PMID: 35243032

Inter- and Intrafraction Motion Assessment and Accumulated Dose Quantification of Upper Gastrointestinal Organs During Magnetic Resonance-guided Ablative Radiation Therapy of Pancreas Patients

Overview
Specialty Oncology
Date 2022 Mar 4
PMID 35243032
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Stereotactic body radiation therapy (SBRT) of locally advanced pancreatic cancer (LAPC) is challenging due to significant motion of gastrointestinal (GI) organs. The goal of our study was to quantify inter and intrafraction deformations and dose accumulation of upper GI organs in LAPC patients.

Materials And Methods: Five LAPC patients undergoing five-fraction magnetic resonance-guided radiation therapy (MRgRT) using abdominal compression and daily online plan adaptation to 50 Gy were analyzed. A pre-treatment, verification, and post-treatment MR imaging (MRI) for each of the five fractions (75 total) were used to calculate intra and interfraction motion. The MRIs were registered using Large Deformation Diffeomorphic Metric Mapping (LDDMM) deformable image registration (DIR) method and total dose delivered to stomach_duodenum, small bowel (SB) and large bowel (LB) were accumulated. Deformations were quantified using gradient magnitude and Jacobian integral of the Deformation Vector Fields (DVF). Registration DVFs were geometrically assessed using Dice and 95th percentile Hausdorff distance (HD95) between the deformed and physician's contours. Accumulated doses were then calculated from the DVFs.

Results: Median Dice and HD95 were: Stomach_duodenum (0.9, 1.0 mm), SB (0.9, 3.6 mm), and LB (0.9, 2.0 mm). Median (max) interfraction deformation for stomach_duodenum, SB and LB was 6.4 (25.8) mm, 7.9 (40.5) mm and 7.6 (35.9) mm. Median intrafraction deformation was 5.5 (22.6) mm, 8.2 (37.8) mm and 7.2 (26.5) mm. Accumulated doses for two patients exceeded institutional constraints for stomach_duodenum, one of whom experienced Grade1 acute and late abdominal toxicity.

Conclusion: LDDMM method indicates feasibility to measure large GI motion and accumulate dose. Further validation on larger cohort will allow quantitative dose accumulation to more reliably optimize online MRgRT.

Citing Articles

A Vessel Bifurcation Landmark Pair Dataset for Abdominal CT Deformable Image Registration (DIR) Validation.

Criscuolo E, Hao Y, Zhang Z, McKeown T, Yang D ArXiv. 2025; .

PMID: 39876932 PMC: 11774459.


Comparison of online adaptive and non-adaptive magnetic resonance image-guided radiation therapy in prostate cancer using dose accumulation.

Murr M, Wegener D, Boke S, Gani C, Monnich D, Niyazi M Phys Imaging Radiat Oncol. 2024; 32:100662.

PMID: 39554802 PMC: 11564916. DOI: 10.1016/j.phro.2024.100662.


Tools and recommendations for commissioning and quality assurance of deformable image registration in radiotherapy.

Bosma L, Hussein M, Jameson M, Asghar S, Brock K, McClelland J Phys Imaging Radiat Oncol. 2024; 32:100647.

PMID: 39328928 PMC: 11424976. DOI: 10.1016/j.phro.2024.100647.


Data Science Opportunities To Improve Radiotherapy Planning and Clinical Decision Making.

Deasy J Semin Radiat Oncol. 2024; 34(4):379-394.

PMID: 39271273 PMC: 11698470. DOI: 10.1016/j.semradonc.2024.07.012.


A multi-institutional comparison of retrospective deformable dose accumulation for online adaptive magnetic resonance-guided radiotherapy.

Murr M, Bernchou U, Bubula-Rehm E, Ruschin M, Sadeghi P, Voet P Phys Imaging Radiat Oncol. 2024; 30:100588.

PMID: 38883145 PMC: 11176923. DOI: 10.1016/j.phro.2024.100588.


References
1.
Rudra S, Jiang N, Rosenberg S, Olsen J, Roach M, Wan L . Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer. Cancer Med. 2019; 8(5):2123-2132. PMC: 6536981. DOI: 10.1002/cam4.2100. View

2.
Magallon-Baro A, Loi M, Milder M, Granton P, Zolnay A, Nuyttens J . Modeling daily changes in organ-at-risk anatomy in a cohort of pancreatic cancer patients. Radiother Oncol. 2019; 134:127-134. DOI: 10.1016/j.radonc.2019.01.030. View

3.
Herman J, Wild A, Wang H, Tran P, Chang K, Taylor G . Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results. J Clin Oncol. 2013; 31(7):886-94. PMC: 4820756. DOI: 10.1200/JCO.2012.44.7516. View

4.
Brock K, Mutic S, McNutt T, Li H, Kessler M . Use of image registration and fusion algorithms and techniques in radiotherapy: Report of the AAPM Radiation Therapy Committee Task Group No. 132. Med Phys. 2017; 44(7):e43-e76. DOI: 10.1002/mp.12256. View

5.
McDonald B, Vedam S, Yang J, Wang J, Castillo P, Lee B . Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation. Int J Radiat Oncol Biol Phys. 2020; 109(5):1606-1618. PMC: 7965360. DOI: 10.1016/j.ijrobp.2020.12.015. View